• NEBANNER

Newly Arrival Zuclopenthixol Tablets - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN

Newly Arrival Zuclopenthixol Tablets - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We normally think and practice corresponding towards the change of circumstance, and grow up. We aim at the achievement of a richer mind and body plus the living for Kitchen Water Filter Systems, Sodium Chlorite Water Purification, Diy Crystal Glue Jewelry, Standing still today and searching into the long run, we sincerely welcome shoppers all around the globe to cooperate with us.
Newly Arrival Zuclopenthixol Tablets - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN Detail:

It works by stimulating central presynaptic alpha 2- receptors. Its hypotensive effect is similar to that of nifedipine, a calcium antagonist, and captopril, an ACE inhibitor. For essential hypertension.

This product should adopt the principle of individualized medication. Generally start from the lowest dose, that is, 0.2mg, once a day, taken in the morning. Dosage adjustments should be made at three-week intervals until satisfactory results are obtained. The usual dose is 0.2mg once, twice a day (morning and evening). The maximum dose per time shall not exceed 0.4mg, and the maximum daily dose shall not exceed 0.6mg. For patients with mild or moderate renal insufficiency, the single dose should not exceed 0.2 mg or the daily dose should not exceed 0.4 mg.

This product is an α2-receptor agonist, which is an imidazoline antihypertensive drug. Used for moderate and severe primary and secondary hypertension.

Because it inhibits the secretion and movement of the gastrointestinal tract, it is also suitable for hypertensive patients suffering from ulcer disease. The combination of this medicine and diuretics can significantly improve the efficacy. It is a powerful central antihypertensive drug and a second-line antihypertensive drug. It is mainly administered locally in ophthalmology. This product has the effect of reducing intraocular pressure, and does not affect the pupil and eye adjustment mechanism. It can constrict blood vessels in the eye, reduce the production of aqueous humor, and achieve the effect of reducing intraocular pressure. It starts to take effect 15 minutes after the eye drops and can maintain the effect for about 8 hours.

Standard:EP10
Assay content:97.5-102.0%

Exterior: White or almost while powder
Package: 1kg/bag or as required by customers


Product detail pictures:

Newly Arrival Zuclopenthixol Tablets - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN detail pictures


Related Product Guide:

To be a result of ours specialty and repair consciousness, our corporation has won a good popularity amid consumers everywhere in the environment for Newly Arrival Zuclopenthixol Tablets - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN , The product will supply to all over the world, such as: Croatia, Algeria, Jeddah, They're durable modeling and promoting effectively all over the world. Under no circumstances disappearing major functions in a quick time, it's a should for you of excellent good quality. Guided by the principle of "Prudence, Efficiency, Union and Innovation. the company make a terrific efforts to expand its international trade, raise its company profit and raise its export scale. We're confident that we are going to possess a vibrant prospect and to be distributed all over the world within the years to come.
  • High production efficiency and good product quality, fast delivery and completed after-sale protection, a right choice, a best choice.
    5 Stars By Lydia from Libya - 2018.12.25 12:43
    The goods are very perfect and the company sales manager is warmful, we will come to this company to purchase next time.
    5 Stars By Gary from Kyrgyzstan - 2017.05.31 13:26
    Write your message here and send it to us